weight loss drug
2024.12.25
16:12
Lilly's weight loss drug sold on Chinese e-commerce platforms
A number of e-commerce platforms in China have already provided treatment pickup services for Eli Lilly's glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide (trade name: Mounjaro).
2024.12.23
22:33
Novo Nordisk rebounded by more than 4%
Novo Nordisk rebounded more than 4%, as analysts said the company's weight loss drugs are still the most effective.
2024.12.21
05:37
Eli Lilly's weight-loss drug Zepbound approved for sleep apnea
Eli Lilly's weight loss drug Zepbound has been approved to treat sleep apnea.
2024.12.20
22:33
Eli Lilly (LLY.N) rose more than 4% as rival Novo Nordisk's weight loss drug trial results fell short of expectations.
19:12
Novo Nordisk's pre-market decline in US stocks narrowed to 20%, while Eli Lilly rose more than 10%
Novo Nordisk's pre-market decline narrowed to 20%, after a sharp drop of nearly 30%, the largest single-day drop on record, due to the company's weight loss drug CagriSema trial results falling short of expectations. Eli Lilly's pre-market rise was more than 10%.
19:04
Novo Nordisk shares plunge 27%, dragging down Stoxx Europe 600 2%
The Stoxx Europe 600 index fell 2% to 496.52 points. Novo Nordisk shares plunged 27%, the biggest one-day drop in 22 years, as the results of the Novo Nordisk weight loss drug CagriSema trial fell short of expectations. Novo Nordisk said on Friday that its experimental next-generation obesity drug CagriSema helped overweight patients lose 22.7% of their weight in a late-stage trial, lower than its expected 25%, causing its shares to fall sharply.
19:01
Novo Nordisk shares plunged 23%, their biggest one-day drop in 22 years, after the company's weight-loss drug CagriSema trial results fell short of expectations.
18:55
The Euro Stoxx Healthcare index fell 4.4%, its biggest one-day drop since March 2020, hit by the results of Novo Nordisk's weight loss drug trial.
18:53
Novo Nordisk fell more than 19 percent in premarket trading after the company reported weaker-than-expected data for its weight-loss drug Cagrisema, while Eli Lilly (LLY.N) rose nearly 6 percent in premarket trading.
2024.12.14
00:01
Novo Nordisk's weight loss drug Ozempic linked to rare vision loss, study shows
Novo Nordisk's weight loss drug Ozempic is linked to a rare form of vision loss, a study has found, with a small number of patients experiencing decreased vision.
2024.12.11
02:23
Eli Lilly (LLY.N) CEO: The company will test weight loss drugs on smokers and alcoholics.
02:23
Eli Lilly CEO: Company will test weight loss drugs on smokers and alcoholics
Eli Lilly's CEO said the company will test its weight-loss drug on smokers and alcoholics.
2024.12.09
21:39
Celebrity weight loss drug tirzepatide and new version of semaglutide said to be launched on Meituan
On December 9, some netizens discovered that oral semaglutide was first sold on Meituan in China, search keywords to place orders first.
2024.12.04
22:31
U.S. stock market opens: three major indexes open higher
The three major U.S. stock indexes opened higher, with the Dow Jones Industrial Average up 0.44%, the Nasdaq up 0.57%, and the S&P 500 up 0.31%. Chip company Marvell rose nearly 16%, with strong demand for AI, and the company's sales increased by 19% month-on-month, far exceeding expectations. Eli Lilly rose nearly 2%, and Eli Lilly's weight loss drug Zepbound surpassed Novo Nordisk's Wegovy in the first comparative trial.
19:48
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in first comparative trial
Eli Lilly's weight loss drug Zepbound outperformed Novo Nordisk's Wegovy in the first comparative trial. (Sina)
Load More
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
Weekly Highlights
Taiwan's weighted index rose 2.6%, with semiconductor stocks leading the gains, and TSMC rising more than 4%

2024-12-23

Huawei's Automotive BU spin-off is in the countdown, and old employees are expected to receive extra compensation when they transfer to other companies? Insider: I haven't heard of it.

2024-12-27

Tuanmaimai, the WeChat community group buying business under Meituan (03690.HK), issued an announcement stating that due to platform business adjustments, Tuanmaimai will cease operations from 24:00 on December 31, 2024.

2024-12-23

Mao Yinian, Vice President of Meituan: Meituan has invested in several robot companies including Yushu and Galaxy General

2024-12-27

A-share SMIC rose more than 5%

2024-12-27

ASIA TECH WIRE

Grasp technology trends

Download